2021 Seminars

September 29
See the agenda for our second annual PACE Day Here

September 6
Dr. Xinyi (Cindy) Li
Rutgers University
"The role of obesity- associated neurobiological adaptations in altering morphine withdrawal responses"

June 21
Delaney Fischer
Ph.D. Candidate in the Department of Neuroscience
The University of Pennsylvania
"Clinical and Functional Connectivity Outcomes of 5-Hz Repetitive Transcranial Magnetic Stimulation as an Add-on Treatment in Cocaine Use Disorder:  A Double-Blind Randomized Controlled Trial"

June 16
Dr. David Matuskey
Yale University
"PET Imaging of the Kappa Opioid Receptor"

June 9
Dr. Jennifer Coughlin
John Hopkins University
"Imaging neuroinflammation with PET"

June 8
Dr. Richard Crist
Journal Club
"Single Cell Transcriptomics in Schizophrenia Postmortem Brain: Moving Beyond Bulk"

May 24
Darrell Eacret
Ph.D. Candidate in the Department of Pharmacology
The University of Pennsylvania
"Sun , et al. Seasonal Variation in the Brain l-Opioid Receptor Availability"

May 11
Maria Oquendo, M.D.
Journal Club
"Imaging suicidality phenotypes with PET molecular imaging"

May 6
Special Seminar— Dr. Nora D. Volkow, M.D.
Director of the National Institute on Drug Abuse (NIDA)
National Institutes of Health
"Opioid Use Disorder and Other Substance Use in the Era of COVID-19"

April 26
Daniel Kalamarides
Ph.D. Candidate
The Perelman School of Medicine at the University of Pennsylvania
"Cannabidiol (CBD) for the Reduction of Cue-Induced Craving and Anxiety in Drug-Abstinent Individuals With Heroin Use Disorder: A Double-Blind Randomized Placebo-Controlled Trial Am J Psychiatry 2019; 176:911–922; doi: 10.1176/appi.ajp. 2019.18"

April 12
Amy Newman, Ph.D.
Scientific Director, NIDA IRP
Chief, Molecular Targets and Medications Discovery Branch
Chief, Medicinal Chemistry Section
Director, Medication Development Program
“Directing Bitopic or Bivalent Molecules to Dopamine D3 Receptors for the Treatment of Substance Use Disorders”
Watch the event here

March 29
Ali Ely, Ph.D.
Postdoctoral Fellow in the Department of Psychiatry
Perelman School of Medicine at the University of Pennsylvania
"Canchy, L., Girardeau, P., Durand, A. et al. Pharmacokinetics trumps pharmacodynamics during cocaine choice: a reconciliation with the dopamine hypothesis of addiction. Neuropsychopharmacol. 46, 288–296 (2021)."
Watch the event here

March 22
Ansel Hillmer, Ph.D.
Assistant Professor of Radiology and Biomedical Imaging and of Psychiatry
Yale School of Medicine
“Pharmacokinetic neuroimaging to study the dose-related brain kinetics and target engagement of buprenorphine in vivo.”
Watch the event here

March 15
Patrick Worhunsky, DPhil
Assistant Professor of Psychiatry
Yale School of Medicine
“Independent Component Analysis of MRI and PET, unmixing addiction in the brain.”
Watch the event here

February 22
Dr. Aladdin Riad
Journal Club
"You, et al. Dopamine D 3 R antagonist VK4-116 attenuates oxycodone self-administration and reinstatement 18-0284-5."

February 1
Dr. Yuri Persidsky
Temple University
"Adventures at the intersection of HIV, neuroinflammation, and drugs of abuse: new understanding and novel therapeutics"

January 25
Dr. Amelia Dunn
Journal Club
"Kraft, et al._Buprenorphine for the Treatment of the Neonatal Abstinence Syndrome N Engl J Med 2017;376:2341-8."